Recherche
-
Correction: Overview of the current use of levosimendan in France: a prospective observational cohort study.
(Annals of Intensive Care. vol. 13, n° 1, pp. 94, 2023-09-29)Article de revueLibre accès -
Factor H's Control of Complement Activation Emerges as a Significant and Promising Therapeutic Target for Alzheimer's Disease Treatment.
(International Journal of Molecular Sciences. vol. 25, n° 4, 2024-02-14)Article de revueLibre accès -
Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility.
(Nature Genetics. vol. 54, n° 3, pp. 232-239)Article de revueLibre accès -
Kidney Function Decline and Serious Adverse Drug Reactions in Patients With CKD
(American Journal of Kidney Diseases, 2023-11)Article de revueLibre accès -
Correction: Autophagy protein 5 controls flow-dependent endothelial functions.
(Cellular and Molecular Life Sciences. vol. 80, n° 9, pp. 275, 2023-09-04)Article de revueLibre accès -
A hexokinase isoenzyme switch in human liver cancer cells promotes lipogenesis and enhances innate immunity
(Communications Biology. vol. 4, n° 1, 2021-02-16)Article de revueLibre accès -
Hospital Production of Sterile 2% Propofol Nanoemulsion: Proof of Concept.
(Pharmaceutics. vol. 15, n° 3, 2023-03-10)Article de revueLibre accès -
Overview of the current use of levosimendan in France: a prospective observational cohort study
(Annals of Intensive Care. vol. 13, n° 1, pp. 69, 2023-12)Article de revueLibre accès -
CRISPR-Cas9 globin editing can induce megabase-scale copy-neutral losses of heterozygosity in hematopoietic cells
(Nature Communications. vol. 12, n° 1, 2021-08-13)Article de revueLibre accès -
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis
(JAMA neurology. vol. 81, n° 3, pp. 273-282, 2024-03-01)Article de revueLibre accès